From: Development and validation of oral chemotherapy self-management scale
characteristics | N(%) or (Mean ± SD) |
---|---|
Age Mean, years(SD) | 54.78 ± 10.03 |
Gender | |
Male | 155(59.4%) |
Female | 106(40.6%) |
Civil status | |
Married | 236(90.4%) |
Single | 7(2.7%) |
Divorced | 2(0.8%) |
Widowed | 9(3.4%) |
misses | 7(2.7%) |
Employment situation | |
Unemployed | 80(30.7%) |
Working | 84(32.2%) |
Retired | 52(19.9%) |
others | 45(17.2%) |
Level of education | |
Without studies | 26(10.0%) |
Primary education | 69(26.4%) |
Secondary education | 135(51.7%) |
University education | 31(11.9%) |
Disease | |
Rectum cancer | 96(36.8%) |
Colon cancer | 70(26.8%) |
Gastric cancer | 47(18.0%) |
Breast cancer | 20(7.7%) |
Others | 28(10.7%) |
Course of disease, months(SD) | 54.84 ± 10.19 |
Medication | |
Capecitabine Capsule | 133(51.0%) |
Xelode Capsule | 66(25.3%) |
Tegafur Gimeracil Oteracil Potassium Capsule | 55(21.1%) |
Others | 7(2.7%) |